| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/06/1999 | EP0912520A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912189A1 Use of artichoke (cynara) extracts |
| 05/06/1999 | EP0912178A1 Methods of treating hypertension |
| 05/06/1999 | EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation |
| 05/06/1999 | EP0634171B1 Pharmaceutical composition for treating cerebral thrombosis |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2307953A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | CA2307952A1 4, 5-diaryloxazole compounds |
| 05/06/1999 | CA2307889A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method |
| 05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1216042A Carboxylic acid derivs, their production and use |
| 05/05/1999 | CN1216041A Carboxylic acid derivs, their production and use |
| 05/05/1999 | CN1215725A Triterpene derivatives and endothelin-receptor antagonists containing the same |
| 05/05/1999 | CN1215724A Novel compounds |
| 05/05/1999 | CN1043230C Serotoninergic ergoline derivs. |
| 05/04/1999 | US5900477 Use of hemoglobin in the treatment of hemorrhagic shock |
| 05/04/1999 | US5900436 Therapy for lipid metabolism disorders |
| 05/04/1999 | US5900403 Use of iron hemoprotein for treating pathogenic syndrome caused by nitric oxide overproduction |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/03/1999 | CA2252733A1 Sulfonamide-substituted benzopyran derivatives, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/30/1999 | CA2249056A1 Lacc |
| 04/29/1999 | WO1999020759A1 Chemokines with amino-terminal modifications |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020622A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 04/29/1999 | WO1999020621A1 ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 04/29/1999 | WO1999020599A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020291A2 Pharmaceutical grade ginkgo biloba |
| 04/29/1999 | WO1999020281A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
| 04/29/1999 | WO1999020275A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020251A1 Use of inhaled no as anti-inflammatory agent |
| 04/29/1999 | WO1999020110A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | WO1999007354A3 Compositions, apparatus and methods for facilitating surgical procedures |
| 04/29/1999 | WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 04/29/1999 | WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 04/29/1999 | WO1999004636A9 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 04/29/1999 | WO1999003822A9 Bicyclic metabotropic glutamate receptor ligands |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | DE19747261A1 Single-chamber osmotic pharmaceutical release system |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | CA2307597A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | CA2307194A1 Pharmaceutical grade ginkgo biloba |
| 04/29/1999 | CA2307114A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |
| 04/29/1999 | CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | CA2306960A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2306825A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | CA2306646A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910565A1 Amide derivatives as selective neuropeptide y receptor antagonists |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910563A1 Integrin receptor antagonists |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910397A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 04/28/1999 | EP0910371A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0910355A1 Traitement and prevention of adverse effects of reactive oxygen species |
| 04/28/1999 | EP0910354A1 Antioxidant compounds |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215335A Method fo treating heart failure with endothelin antagonists |
| 04/28/1999 | CN1214931A Medicine for curing atherosclerosis |
| 04/28/1999 | CN1043140C Hydroxymethyl furazane carboxylic acid derivatives and its preparation process and medicinal composition |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/23/1999 | CA2245997A1 Novel compounds |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | WO1999019356A1 Trivalent thrombin inhibitor |
| 04/22/1999 | WO1999019351A1 Novel npy family member |